Profile data is unavailable for this security.
About the company
NanJing Pharmaceutical Company Limited is a China-based company principally engaged in the pharmaceutical distribution business. The Company's principal businesses include the pharmaceutical wholesale, pharmaceutical retail, pharmaceutical-Internet + business, as well as the pharmaceutical third-party logistics services. The Company mainly conducts its business in domestic market.
- Revenue in CNY (TTM)53.46bn
- Net income in CNY587.75m
- Incorporated1994
- Employees4.90k
- LocationNanJing Pharmaceutical Co LtdBuilding 8(Nanjng Intrntnl Hlth Indl Prk,No.1 YjXiaoxingli, Yuhuatai DistrictNANJING 210012ChinaCHN
- Phone+86 2 584552601
- Fax+86 2 584552601
- Websitehttps://www.njyy.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shanghai New World Co Ltd | 1.15bn | 33.59m | 3.76bn | 1.20k | 111.90 | 0.8941 | -- | 3.28 | 0.0519 | 0.0519 | 1.77 | 6.50 | 0.2026 | 4.62 | 7.42 | 951,798.10 | 0.5858 | 0.5242 | 0.78 | 0.7249 | 38.56 | 33.70 | 2.89 | 2.71 | 1.52 | -- | 0.1222 | 82.75 | 33.39 | -16.40 | 160.85 | -35.00 | 53.61 | -25.42 |
| NanJing Pharmaceutical Co Ltd | 53.46bn | 587.75m | 6.00bn | 4.90k | 10.15 | 0.9004 | -- | 0.1123 | 0.4513 | 0.4513 | 41.07 | 5.09 | 1.63 | 8.33 | 3.33 | 10,903,610.00 | 2.22 | 2.32 | 7.44 | 8.94 | 6.04 | 6.41 | 1.36 | 1.30 | 1.13 | 2.91 | 0.6359 | 29.82 | 6.71 | 11.35 | -3.00 | 16.93 | -12.67 | 9.86 |
| Guangxi LiuYao Group Co Ltd | 21.25bn | 888.87m | 8.46bn | 5.58k | 8.62 | 1.11 | -- | 0.3983 | 2.46 | 2.46 | 58.82 | 19.12 | 1.07 | 6.99 | 1.97 | 3,807,204.00 | 4.80 | 5.06 | 11.73 | 12.21 | 11.56 | 11.85 | 4.47 | 4.40 | 1.30 | 5.26 | 0.5434 | 29.90 | 9.23 | 12.18 | 21.11 | 9.97 | -8.63 | 6.26 |
Data as of Jun 07 2024. Currency figures normalised to NanJing Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
1.13%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| GF Fund Management Co., Ltd.as of 31 Dec 2023 | 3.56m | 0.34% |
| The Vanguard Group, Inc.as of 30 Apr 2024 | 3.16m | 0.30% |
| Orient Securities Asset Management Co. Ltd.as of 31 Dec 2023 | 1.33m | 0.13% |
| Lion Fund Management Co., Ltd.as of 31 Dec 2023 | 720.00k | 0.07% |
| SWS MU Fund Management Co., Ltd.as of 31 Dec 2023 | 621.20k | 0.06% |
| Bank of China Investment Management Co., Ltd.as of 31 Dec 2023 | 594.60k | 0.06% |
| Shanghai Guotai Junan Securities Assets Management Co., Ltd.as of 31 Dec 2023 | 589.70k | 0.06% |
| HuaAn Fund Management Co., Ltd.as of 31 Dec 2023 | 582.70k | 0.06% |
| Tibet Dongcai Fund Management Co., Ltd.as of 31 Dec 2023 | 370.00k | 0.04% |
| China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 263.40k | 0.03% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
